BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Cisplatin
,
rs2300478
,
TGFB1
,
Metabolism of xenobiotics
,
Pseudomonas infection
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
MFS
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
Plasma cell of spleen
Coronary artery
Parotid gland
Saphenous vein
Bronchus
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Pharyngitis
Sepsis due to Escherichia coli
Systemic inflammatory response syndrome
Liver transplant disorder
Sepsis due to Gram negative bacteria
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Hydralazine
benzo(b)fluoranthene
Ondansetron
styrene oxide
Diseased blood extracts
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
MIR19B1
MIR19A
GGCT
DEAF1
HPS1
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
A novel missense variant in CDK5RAP2 associated with non-obstructive azoospermia.
Association of Meier-Gorlin and microcephalic osteodysplastic primordial dwarfism type II clinical f…
CDK5RAP2 is a Wnt target gene and promotes stemness and progression of oral squamous cell carcinoma.
Cep215 is essential for morphological differentiation of astrocytes.
Congenital microcephaly-linked CDK5RAP2 affects eye development.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Ruxolitinib and Pomalidomide Combination Therapy in Patients With Primary and Secondary MF
MAP to Provide Access to Ruxolitinib, for Patients With PMF or PPV MF or PET-MF
KRT-232 in Combination With TL-895 for the Treatment of R/R MF and KRT-232 for the Treatment of JAKi…
Asian Phase II Study of INC424 in Patients With Primary Myelofibrosis (MF), Post-PV MF or Post-ET MF
Safety and Tolerability Study of Oral NS-018 in Patients With Primary Myelofibrosis (MF), Post-polyc…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ